Imraldi vs. Amjevita

Reviewed on 9/22/2020

Are Imraldi and Amjevita the Same Thing?

Imraldi (adalimumab injection, solution) and Amjevita (adalimumab-atto) injection are tumor necrosis factor (TNF) blockers used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

Side effects of Imraldi and Amjevita that are similar include infections (e.g. upper respiratory, sinusitis, urinary tract infection), injection site reactions, headache, and rash.

Side effects of Amjevita that are different from Imraldi include nausea, abdominal pain, and back pain.

Both Imraldi and Amjevita may interact with abatacept, anakinra, and live vaccines.

What Are Possible Side Effects of Imraldi?

Side effects of Imraldi include:

  • infections (e.g. upper respiratory, sinusitis),
  • injection site reactions,
  • headache, and
  • rash

What Are Possible Side Effects of Amjevita?

Common side effects of Amjevita include:

SLIDESHOW

Types of Psoriasis: Medical Pictures and Treatments See Slideshow

What Is Imraldi?

Imraldi (adalimumab injection, solution) is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

What Is Amjevita?

Amjevita (adalimumab-atto) injection is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps).

What Drugs Interact With Imraldi?

Imraldi may interact with other medicines such as:

  • abatacept,
  • anakinra, and
  • live vaccines

Tell your doctor all medications and supplements you use.

What Drugs Interact With Amjevita?

Amjevita may interact with:

  • anakinra,
  • abatacept, or
  • live vaccines

How Should Imraldi be Taken?

The dose of Imraldi for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis is 40 mg every other week.

The dose of Imraldi for juvenile idiopathic arthritis for patients 30 kg (66 lbs.) or greater and from 4 to 17 years of age is 40 mg every other week.

The initial dose of Imraldi for adult Crohn's disease and ulcerative colitis is 160 mg (four 40 mg injections in one day or two 40 mg injections per day for two consecutive days), and the second dose two weeks later (Day 15) is 80 mg. Two weeks later (Day 29): Begin a maintenance dose of 40 mg every other week.

The initial dose of Imraldi for plaque psoriasis is an 80 mg initial dose, followed by 40 mg every other week starting one week after initial dose.

How Should Amjevita be Taken?

The dose of Amjevita depends on the condition being treated.

QUESTION

Psoriasis causes the top layer of skin cells to become inflamed and grow too quickly and flake off. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Dailymed. Imraldi Product Information

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acdfaa71-27ed-4717-8e7d-f1a5fe0d1fa6

FDA. Amjevita Product Information

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761024lbl.pdf

Health Solutions From Our Sponsors